TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.

Tempus AI, Inc. (NASDAQ:TEM) grew its share prices by 29.7 percent week-on-week to end Friday’s trading at $89.44 apiece ...

Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Below is Validea's guru fundamental report for TEMPUS AI INC (TEM). Of the 22 guru strategies we follow, TEM rates highest using our P/B Growth Investor model based on the published strategy of ...

Design An intervention systematic review with random effects meta-analysis and meta-regression. Data sources MEDLINE, EMBASE, Cochrane Register of Controlled Trials, Allied and Complementary Medicine ...

This study aimed to describe the anterior manifestations of VRL, and their association with molecular testing. Methods Retrospective analysis of patients with biopsy-proven VRL. Study variables ...

Design We performed single-cell RNA sequencing and spatial transcriptomic analysis in primary colorectal cancer (CRC) and metastases in the liver (lCRC) or ovary (oCRC). We also conducted ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Data analysis is now one of the ...

It offers customizable dashboards for better strategy planning and integrates various data sources for comprehensive analysis. Alpha Research provides in-depth analysis of stocks for investors and ...